At the news
? NEUTRALIMPACT 2/10 CLUSTER filed May 4, 2026 at 19:30 ET
Two Edwards Lifesciences executives sold a combined $133K in open-market sales over the past week, a trivial 0.0003% of the company's $44.4B market cap. The cluster also includes routine non-cash derivative exercises and tax withholding transactions by the CEO and other officers, which carry no economic signal. The selling is immaterial relative to company size and likely reflects routine portfolio management.
- Total open-market sales by two C-suite executives: $133K (0.0003% of market cap)
- CEO Bernard Zovighian gifted 32,129 shares ($0 value) and exercised derivatives (non-cash) but made no open-market purchases
- CFO Scott Ullem and other officers exercised derivatives and surrendered shares for tax withholding, all non-cash events
- No insider buying detected in the cluster
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access